- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07433959
Neuromodulation to Improve Grasping Function After SCI
April 20, 2026 updated by: Hang Jin Jo, State University of New York at Buffalo
Neuromodulation to Improve Grasping Function After Spinal Cord Injury
The goal of this study is to restore the activities of late descending signals with a noninvasive stimulation approach in combination with hand motor training to improve hand function in persons with cervical SCI.
The main question it aims to answer is if the inputs to late descending signals above the level of injury and the output of residual late descending signals below the level of injury could be increased.
Specifically, in the first part of the study, 30 participants will complete 2 randomized sessions to compare the effect of intermittent theta burst stimulation combined with paired corticospinal motoneuronal stimulation.
In the second part of the study, 24 participants will complete either combined stimulation protocol or sham stimulation protocol with exercise training.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The investigators will use paired corticospinal-motoneuronal stimulation (PCMS) in combination with intermittent theta burst stimulation (iTBS).
During PCMS, the investigators will use paired stimulation of the primary motor cortex by transcranial magnetic stimulation to elicit late corticospinal descending volleys and the peripheral nerve by electrical stimulation to improve corticospinal transmission and functional recovery in humans with cervical incomplete SCI.
In addition, the investigators will investigate how priming iTBS affects neuroplasticity of late corticospinal descending volleys.
The investigators will apply iTBS on primary motor cortex prior to paired stimulation with PCMS to facilitate late corticospinal volleys and potentiate the effect of PCMS.
In Aim 2, the investigators propose to combine our neuromodulation in Aim 1 with long-term motor training focused on hand grasping to strengthen spared connections and promote functional improvement in humans with cervical incomplete SCI.
Study Type
Interventional
Enrollment (Estimated)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hang Jin Jo, PhD
- Phone Number: 716-829-2905
- Email: hangjinj@buffalo.edu
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14214
- Recruiting
- The State University of New York at Buffalo
-
Contact:
- Karen Barnes
- Phone Number: 716-829-6718
- Email: barneska@buffalo.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
For individuals with SCI:
- Ages 18-75 years
- Chronic SCI (≥1 year of injury)
- Cervical injury at C8 or above
- Individuals who have MEP responses in at least one FDI muscle
Exclusion Criteria:
- Uncontrolled medical problems including pulmonary or cardiovascular disease
- Premorbid, ongoing major depression or psychosis, altered cognitive status
- History of head injury or stroke
- Metal plate in skull
- History of seizures
- Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs
- Pregnant females
- Individuals who suffer from a spinal cord disease such as spinal stenosis, spinal bifida or herniated cervical
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: iTBS and PCMS
iTBS and PCMS will be administered and functional and physiological outcomes will be measured before and after the intervention.
|
Intermittent theta burst stimulation (iTBS) will be utilized since they have been reported to have a cortical neuromodulatory effect.
The iTBS protocol will be applied over primary motor cortex to investigate its effect on corticospinal excitability and functional outcome.
Theta burst stimulation (TBS) consists of bursts of pulses containing 3 pulses at 50 Hz (3 pulses per second) repeated at 200 ms intervals (5 Hz).
During iTBS, a 2 second train of TBS is repeated every 10 seconds (600 pulses in 190 seconds).
During PCMS, paired stimulation of the primary motor cortex by transcranial magnetic stimulation to elicit late corticospinal descending volleys and the peripheral nerve by electrical stimulation will be used to improve corticospinal transmission.
|
|
Sham Comparator: Sham iTBS and PCMS
Sham iTBS and PCMS will be administered and functional and physiological outcomes will be measured before and after the intervention.
|
Sham iTBS protocols will be applied with the same parameters as in iTBS protocol.
However, sham coil will be used.
During PCMS, paired stimulation of the primary motor cortex by transcranial magnetic stimulation to elicit late corticospinal descending volleys and the peripheral nerve by electrical stimulation will be used to improve corticospinal transmission.
|
|
Active Comparator: iTBS and PCMS with exercise
Participants will complete iTBS and PCMS with exercise for 10 sessions.
|
Intermittent theta burst stimulation (iTBS) will be utilized since they have been reported to have a cortical neuromodulatory effect.
The iTBS protocol will be applied over primary motor cortex to investigate its effect on corticospinal excitability and functional outcome.
Theta burst stimulation (TBS) consists of bursts of pulses containing 3 pulses at 50 Hz (3 pulses per second) repeated at 200 ms intervals (5 Hz).
During iTBS, a 2 second train of TBS is repeated every 10 seconds (600 pulses in 190 seconds).
The motor training will be focused on participant's hand motor function such as grasping function.
During PCMS, paired stimulation of the primary motor cortex by transcranial magnetic stimulation to elicit late corticospinal descending volleys and the peripheral nerve by electrical stimulation will be used to improve corticospinal transmission.
|
|
Sham Comparator: Sham iTBS and sham PCMS with exercise
Participants will complete sham stimulation with exercise for 10 sessions.
|
Sham iTBS protocols will be applied with the same parameters as in iTBS protocol.
However, sham coil will be used.
During PCMS, the same parameters will be used as in real PCMS but sham TMS coil will be used with minimum PNS intensity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor evoked potential (MEP)
Time Frame: For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
Transcranial magnetic stimuli (TMS) will be delivered through a figure-of-eight coil over primary motor cortex to the optimal scalp position for activation of hand muscles.
The optimal scalp position will be determined by moving the coil in small steps along the hand representations of the primary motor cortex to find the region where the largest MEP can be evoked with the minimum intensity in the targeted muscle.
Twenty MEPs will be collected and the peak-to-peak amplitude of MEP will be averaged across trials.
|
For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum voluntary contraction (MVC)
Time Frame: For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
Individuals will perform a MVC of the targeted hand muscle (first dorsal interosseous) through surface EMG electrodes.
The investigators will collect two MVC trials and use the average of the two.
|
For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
|
Grip force
Time Frame: For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
Grip force will be assessed with hand grip dynamometer.
The highest value of the three trials will be used.
|
For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
|
Toronto Rehabilitation Institute-Hand Function Test (TRI-HFT)
Time Frame: For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
TRI-HFT is clinical assessment tool to measure specifically unilateral pinch and grasp hand function.
|
For the first study, the time frame will be one day. For the second study, the time frame will be 4 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Study Registration Dates
First Submitted
February 19, 2026
First Submitted That Met QC Criteria
February 19, 2026
First Posted (Actual)
February 25, 2026
Study Record Updates
Last Update Posted (Actual)
April 23, 2026
Last Update Submitted That Met QC Criteria
April 20, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00009877
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injury
-
Ecole Polytechnique Fédérale de LausanneRecruitingChronic Spinal Cord Injury | Spinal Cord Injury (SCI) | Spinal Cord Injury | SCI - Spinal Cord Injury | SCI | Subacute Spinal Cord InjurySwitzerland
-
Lian-Cing Yan, MSPTNot yet recruitingSpinal Cord Injury | Spinal Cord Stimulation | Spinal Cord Injury/Damage | Spinal Cord Injury Thoracic | Spinal Cord Stimulation (SCS) | Spinal Cord Injury T1-L2 | Epidural Electrical StimulationTaiwan
-
Xuanwu Hospital, BeijingBeijing Pins Medical Co., Ltd; Beijing Xinzhida Neural Technology Co., Ltd; Hangzhou...RecruitingSpinal Cord Injury | Motor Deficits | Gait Impairment | Gait Training | Spinal Cord Injury Cervical | Spinal Cord Injuries (SCI) | Motor Impairment | Spinal Cord Injury, Chronic | Spinal Cord Injury Thoracic | Spinal Cord Injury (Quadraplegia)China
-
Taipei Veterans General Hospital, TaiwanThe Industrial Technology Research InstituteUnknownSpinal Cord Injuries | Complete Spinal Cord Injury | Incomplete Spinal Cord InjuryTaiwan
-
Chang Gung Memorial HospitalNot yet recruitingSpine Injury | Complete Spinal Cord Injury | Incomplete Spinal Cord Injury | Cord Injury, Spinal | Cord Infarction Spinal
-
University of FloridaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSCI - Spinal Cord Injury | Incomplete Spinal Cord InjuryUnited States
-
Jill M. Wecht, Ed.D.Icahn School of Medicine at Mount SinaiRecruitingBlood Pressure | Spinal Cord Injuries | SCI - Spinal Cord Injury | Blood Pressure Disorders | Traumatic Spinal Cord Injury | Acute Spinal Cord Injury | Neuromodulation | Spinal Cord StimulationUnited States
-
NervGen PharmaTerminatedSpinal Cord Injuries | Chronic Spinal Cord Injury | Subacute Spinal Cord InjuryUnited States
-
MetroHealth Medical CenterNational Institute of Neurological Disorders and Stroke (NINDS); Case Western...RecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury CervicalUnited States
-
Anne BrydenNational Institute of Neurological Disorders and Stroke (NINDS); Case Western... and other collaboratorsRecruitingSpinal Cord Injuries | Spinal Cord Injury at C5-C7 Level | Spinal Cord Injury Cervical | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C5-C7 Level With Incomplete LesionUnited States
Clinical Trials on iTBS
-
Centre for Addiction and Mental HealthCompleted
-
Centre for Addiction and Mental HealthBrain CanadaRecruiting
-
Stanford UniversityNational Institute of Mental Health (NIMH)Not yet recruitingMajor Depressive Disorder | Treatment Resistant DepressionUnited States
-
Beijing Tiantan HospitalRecruitingCognitive Impairment | Cerebral Small Vessel DiseasesChina
-
Central South UniversityRecruitingSuicidal Ideation | Suicide and Self-harm | Non Suicidal Self InjuryChina
-
Changping LaboratoryChina Rehabilitation Research CenterRecruiting
-
Central South UniversityRecruitingBipolar Depression | Major Depressive DisorderChina
-
Centre for Addiction and Mental HealthUniversity Health Network, Toronto; University of British ColumbiaCompleted
-
Medical University of South CarolinaMUSC Center for Biomedical Research Excellence in Stroke RecoveryCompleted